Peer-reviewedCC BYComprehensive psychoneuroendocrinology
Hair cortisol in a naturalistic sample of outpatients with depressive disorders – A secondary analysis of a randomized-controlled trial and a status update on psychoneuroendocrine markers for clinical practice
- 1Department for Clinical Psychology and Psychotherapy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nägelsbachstr. 25a, Erlangen, 91052, Germany
- 2Department of Psychology, TUD Dresden University of Technology, Fetscherstraße 74, Dresden, 01307, Germany
Related
- Short-Term Effectiveness of a Psychotherapeutic Intervention Model in Nursing for Ineffective Coping in GAD Outpatients: A Small-Sample Randomized Controlled Trial
- Adjunctive Psychobiotic Lactiplantibacillus plantarum PS128 Therapy and Escitalopram in Major Depressive Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial
- Intermittent theta‐burst stimulation versus sham stimulation for suicidal ideation and psychiatric symptoms in depressive disorders: A systematic review and meta‐analysis of randomized controlled trials
- The Effects of a Multi-Strain Probiotic Formulation Containing Saffron Extract and Fructooligosaccharides on Anxiety, Depressive Symptoms, Inflammatory Markers, and BDNF: A Double-Blind, Randomized, Placebo-Controlled Pilot Study
- Psychological Correlates of Self-Harm Ideation Among Depressive Outpatients: The Roles of Rumination and Depressive Symptom Severity
BibTeX
@article{schindlergmelch2026hair,
title = {{Hair cortisol in a naturalistic sample of outpatients with depressive disorders – A secondary analysis of a randomized-controlled trial and a status update on psychoneuroendocrine markers for clinical practice}},
author = {Lena Schindler-Gmelch and Lukas Moses Fuhrmann and Susann Steudte-Schmiedgen and Matthias Berking},
journal = {Comprehensive psychoneuroendocrinology},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13660528},
note = {CC BY},
}
RIS
TY - JOUR
TI - Hair cortisol in a naturalistic sample of outpatients with depressive disorders – A secondary analysis of a randomized-controlled trial and a status update on psychoneuroendocrine markers for clinical practice
AU - Lena Schindler-Gmelch
AU - Lukas Moses Fuhrmann
AU - Susann Steudte-Schmiedgen
AU - Matthias Berking
PY - 2026
DA - 2026/09/24
JO - Comprehensive psychoneuroendocrinology
UR - https://europepmc.org/article/PMC/PMC13660528
SN - 2666-4976
ER -